
Juanita Dionne Jackson
Examiner (ID: 392)
| Most Active Art Unit | 2853 |
| Art Unit(s) | 2853, 2108 |
| Total Applications | 2176 |
| Issued Applications | 2044 |
| Pending Applications | 21 |
| Abandoned Applications | 123 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14647583
[patent_doc_number] => 20190230920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => 3D SPACER TEXTILES FOR CROP PROTECTION AND INSECT CONTROL
[patent_app_type] => utility
[patent_app_number] => 16/258574
[patent_app_country] => US
[patent_app_date] => 2019-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16258574
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/258574 | 3D spacer textiles for crop protection and insect control | Jan 25, 2019 | Issued |
Array
(
[id] => 16105759
[patent_doc_number] => 10695465
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Microgel compositions
[patent_app_type] => utility
[patent_app_number] => 16/253707
[patent_app_country] => US
[patent_app_date] => 2019-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 59
[patent_no_of_words] => 25969
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16253707
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/253707 | Microgel compositions | Jan 21, 2019 | Issued |
Array
(
[id] => 16275470
[patent_doc_number] => 10758477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Radiation sensitizer or anti-cancer chemotherapy sensitizer
[patent_app_type] => utility
[patent_app_number] => 16/244015
[patent_app_country] => US
[patent_app_date] => 2019-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8350
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16244015
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/244015 | Radiation sensitizer or anti-cancer chemotherapy sensitizer | Jan 8, 2019 | Issued |
Array
(
[id] => 18522181
[patent_doc_number] => 20230232829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => HIGH-LOAD HALOXYFOP ESTER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/959927
[patent_app_country] => US
[patent_app_date] => 2019-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959927
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959927 | HIGH-LOAD HALOXYFOP ESTER COMPOSITIONS | Jan 2, 2019 | Pending |
Array
(
[id] => 16671213
[patent_doc_number] => 20210059976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => ORAL PHARMACEUTICAL FORMULATION COMPRISING CANNABINOIDS AND POLOXAMER
[patent_app_type] => utility
[patent_app_number] => 16/959357
[patent_app_country] => US
[patent_app_date] => 2019-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959357
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959357 | ORAL PHARMACEUTICAL FORMULATION COMPRISING CANNABINOIDS AND POLOXAMER | Jan 1, 2019 | Abandoned |
Array
(
[id] => 16108283
[patent_doc_number] => 20200206164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => METHODS AND APPARATUS FOR TREATING A WOUND
[patent_app_type] => utility
[patent_app_number] => 16/234867
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16234867
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/234867 | Methods and apparatus for treating a wound | Dec 27, 2018 | Issued |
Array
(
[id] => 16397095
[patent_doc_number] => 20200337953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => EMULSIFIED COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/958897
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7306
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958897
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958897 | EMULSIFIED COMPOSITION | Dec 27, 2018 | Abandoned |
Array
(
[id] => 17457901
[patent_doc_number] => 20220071205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => HERBICIDE
[patent_app_type] => utility
[patent_app_number] => 17/414458
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414458
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/414458 | HERBICIDE | Dec 20, 2018 | Pending |
Array
(
[id] => 17412722
[patent_doc_number] => 20220047626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => COMPOSITION OF A SPRAY FORMULA TO CONTROL MASTITIS IN BOVINES
[patent_app_type] => utility
[patent_app_number] => 17/416054
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416054
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416054 | COMPOSITION OF A SPRAY FORMULA TO CONTROL MASTITIS IN BOVINES | Dec 17, 2018 | Abandoned |
Array
(
[id] => 14464333
[patent_doc_number] => 20190183806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => PACKAGED MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED STABILITY
[patent_app_type] => utility
[patent_app_number] => 16/223940
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16223940
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/223940 | PACKAGED MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED STABILITY | Dec 17, 2018 | Abandoned |
Array
(
[id] => 14213617
[patent_doc_number] => 20190119193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => COMPOSITION FOR REGULATING PLANT GROWTH, METHOD FOR TREATING PLANTS THEREWITH, AND ACTIVE INGREDIENT THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/221147
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 638
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16221147
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/221147 | COMPOSITION FOR REGULATING PLANT GROWTH, METHOD FOR TREATING PLANTS THEREWITH, AND ACTIVE INGREDIENT THEREOF | Dec 13, 2018 | Abandoned |
Array
(
[id] => 18451474
[patent_doc_number] => 20230192752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => THERAPEUTIC AGENT FOR BLOOD CANCER
[patent_app_type] => utility
[patent_app_number] => 16/609367
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609367
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609367 | THERAPEUTIC AGENT FOR BLOOD CANCER | Nov 29, 2018 | Pending |
Array
(
[id] => 16466816
[patent_doc_number] => 20200368353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => SYSTEMS AND METHODS FOR TOPICAL CREAMS FOR WARMING
[patent_app_type] => utility
[patent_app_number] => 16/762261
[patent_app_country] => US
[patent_app_date] => 2018-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762261
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762261 | SYSTEMS AND METHODS FOR TOPICAL CREAMS FOR WARMING | Nov 25, 2018 | Abandoned |
Array
(
[id] => 16450896
[patent_doc_number] => 20200360322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => FORMULATIONS AND DOSAGE FORMS FOR ENHANCING PERFORMANCE OR RECOVERY FROM STRESS
[patent_app_type] => utility
[patent_app_number] => 16/763532
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -142
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763532
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/763532 | FORMULATIONS AND DOSAGE FORMS FOR ENHANCING PERFORMANCE OR RECOVERY FROM STRESS | Nov 14, 2018 | Abandoned |
Array
(
[id] => 18201126
[patent_doc_number] => 11583497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Nano-emulsion of CBFss-RUNX1 inhibitor for ocular drug delivery
[patent_app_type] => utility
[patent_app_number] => 16/763932
[patent_app_country] => US
[patent_app_date] => 2018-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 32
[patent_no_of_words] => 16830
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763932
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/763932 | Nano-emulsion of CBFss-RUNX1 inhibitor for ocular drug delivery | Nov 13, 2018 | Issued |
Array
(
[id] => 14564095
[patent_doc_number] => 20190209654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => Biodegradable Drug Delivery Composition
[patent_app_type] => utility
[patent_app_number] => 16/179704
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16179704
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/179704 | Biodegradable Drug Delivery Composition | Nov 1, 2018 | Abandoned |
Array
(
[id] => 15828313
[patent_doc_number] => 20200129438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => FINISHED PHARMACEUTICAL DOSAGE FORM COMPRISING A LOW DOSE/HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT AND ONE OR MORE EXCIPIENTS
[patent_app_type] => utility
[patent_app_number] => 16/176888
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16176888
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/176888 | FINISHED PHARMACEUTICAL DOSAGE FORM COMPRISING A LOW DOSE/HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT AND ONE OR MORE EXCIPIENTS | Oct 30, 2018 | Abandoned |
Array
(
[id] => 16655888
[patent_doc_number] => 20210052524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => N-ACETYLCYSTEINE AND UREA-BASED FORMULATION FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/967265
[patent_app_country] => US
[patent_app_date] => 2018-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967265
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967265 | N-ACETYLCYSTEINE AND UREA-BASED FORMULATION FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS | Oct 28, 2018 | Abandoned |
Array
(
[id] => 16341575
[patent_doc_number] => 20200306225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => STABLE N-((1R,2R)-1-(2,3-DIHYDROBENZO[B][1,4]DIOXIN-6-YL)-1-HYDROXY-3-(PYRROLIDIN-1-YL)PROPAN-2-YL) OCTANAMIDE (2R,3R)-2,3-DIHYDROXYSUCCINATE PREMIX AND PROCESS FOR PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/759710
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16759710
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/759710 | STABLE N-((1R,2R)-1-(2,3-DIHYDROBENZO[B][1,4]DIOXIN-6-YL)-1-HYDROXY-3-(PYRROLIDIN-1-YL)PROPAN-2-YL) OCTANAMIDE (2R,3R)-2,3-DIHYDROXYSUCCINATE PREMIX AND PROCESS FOR PREPARATION THEREOF | Oct 25, 2018 | Abandoned |
Array
(
[id] => 18503559
[patent_doc_number] => 11701349
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Pharmaceutical composition containing quinoline derivative
[patent_app_type] => utility
[patent_app_number] => 16/757363
[patent_app_country] => US
[patent_app_date] => 2018-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2684
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757363
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757363 | Pharmaceutical composition containing quinoline derivative | Oct 22, 2018 | Issued |